Shortage in prescription drug supply possible

Posted in Latest News on January 19, 2017.

The DEA recently suspended McKesson Corporation’s sales of controlled substances from distribution in Florida. This suspension could impact your patients’ ability to fill their prescriptions and you may want to advise them about the potential implications. As a practitioner, you should be aware of the possibility of drug shortages and consider alternative treatment options when prescribing controlled substances. As always, use your best professional judgment when caring for your patients.

Please see the link to the news release below: https://www.dea.gov/divisions/hq/2017/hq011717.shtml



More Latest News

Rule 64B3-3.001
December 12, 2018

Please click here to read more information regarding the recent changes to the “General Requirements of Clinical Laboratory Personnel Training Programs.” Continue reading


Dental Sedation Workshop
December 11, 2018

Click here for more information about the Dental Sedation Workshop that will take place on February 14, 2019. Continue reading